PZOO Company Profile and Key Details

The stock is currently trading near its 52-week high $0.00 and $0.00. With a market capitalization of about $26.88 thousand, Pazoo, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~6.79). Key stats such as the average daily volume over the past year has been around 30.15 thousand shares, volume is running light vs its 52-week average. Headquartered in East Hanover, NJ, Pazoo, Inc. operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Steven Basloe, the company employs approximately 3 people and listed since June 27, 2012. Pazoo, Inc. operates as a health and wellness company.

Our AI price prediction model suggests that Pazoo, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Valuation shows Pazoo, Inc. trading at a premium to the broader market with a P/E of -0.0.

Pazoo, Inc. trades at a P/E ratio of -0.0, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 The P/FCF stands at -0.03, also above market averages.